Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the molecular formula C25H36N4O4 and a molecular weight of approximately 456.6 g/mol. It belongs to the class of organic compounds known as n-carbamoyl-alpha amino acids and derivatives. There is no evidence that it has been approved for any medical use or entered clinical trials; it appears to be an experimental or research compound with no established mechanism of action, therapeutic indication, or developer information available in public databases[2][8][9]. Its structure features a morpholine carboxamide core substituted with benzyloxy, cyano, cyclohexylmethyl groups.
- Other names
- (2S)-N-((1R)-2-(benzyloxy)-1-cyano-1-methylethyl)-3-cyclohexyl-2-((morpholine-4-carbonyl)amino)propanamide(2S)-N-[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]-3-cyclohexyl-2-(morpholine-4-carbonylamino)propanamideN-((1S)-2-(((1R)-2-(benzyloxy)-1-cyano-1-methylethyl)amino)-1-(cyclohexylmethyl)-2-oxoethyl)morpholine-4-carboxamide
Beyond the preview
Go deeper on N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide.